Wandercraft Partners With NSM for U.S. Sales of Home Exoskeleton Eve

Wandercraft announced June 25 that it had appointed National Seating & Mobility (NSM) as the exclusive U.S. CRT distributor for its home exoskeleton Eve. Eve is currently under FDA review. If approved, NSM will support evaluations, education and delivery through more than 180 locations.

Eve is under review for approval in the United States as a personal exoskeleton for home use by people with severe mobility impairments, including those resulting from spinal cord injuries. If approved, NSM will handle evaluations, education and delivery through more than 180 locations, giving clinicians and users a clearer picture of the process for bringing the device into the home.